Fri, May 30, 2025
Volume 18, Issue 5 (Sep-Oct 2024)
mljgoums 2024, 18(5): 4-7 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sudhaharan S, Sundarapu N A R, Pamidimukkala U. Comparison of Vitek 2C antifungal susceptibility testing with broth microdilution testing for Candida species. mljgoums 2024; 18 (5) :4-7
URL: http://mlj.goums.ac.ir/article-1-1656-en.html
URL: http://mlj.goums.ac.ir/article-1-1656-en.html
1- Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India , sukanyavimala@gmail.com
2- Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India
2- Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India
Abstract: (971 Views)
Background: The reference method for antifungal susceptibility testing is broth microdilution according to Clinical and Laboratory Standard Institute (CLSI) guidelines. However, the fully automated system, Vitek 2C system may reduce the workload and observer bias associated with manual broth microdilution. This study aimed to compare the results of YS08 card with the results of the broth microdilution (BMD) method.
Methods: A total of 50 clinical Candida isolates were included in the study. The susceptibility testing was done by Vitek 2C using the YS08 card. Broth microdilution was done according to CLSI guidelines M27M44S-Ed3.
Results: For C. albicans, the categorical agreement was 85.8%, 71.5%, 85.8%, and 100% for fluconazole, voriconazole, caspofungin, and micafungin, respectively. The minor errors (MiE) of 14.2% for fluconazole and caspofungin, 28.5% for voriconazole, were detected in C. albicans. In C. glabrata, the categorical agreement (CA) was 100% for micafungin, voriconazole, but 63.7% for caspofungin. An MiE of 36.3% was detected for caspofungin. C. parapsilosis showed a 100% CA for fluconazole, caspofungin, and micafungin, and 85.8% for voriconazole. There were 14.2% of MiEs for voriconazole. In C. tropicalis, 100 % CA was observed for fluconazole, micafungin, and caspofungin, and 88.9% for voriconazole. Moreover, 11.1% (1/9) of MiEs was observed for voriconazole. In C. auris, there was a 100% CA for caspofungin and micafungin, 77.8% for fluconazole, and 66.7% for amphotericin B. There was a major error of 22.2% for fluconazole and 33.3% for amphotericin B.
Conclusion: The majority of Vitek 2C showed comparable results with the broth microdilution (BMD) method. Only minor errors (MiEs) were observed in the tested Candida species.
Methods: A total of 50 clinical Candida isolates were included in the study. The susceptibility testing was done by Vitek 2C using the YS08 card. Broth microdilution was done according to CLSI guidelines M27M44S-Ed3.
Results: For C. albicans, the categorical agreement was 85.8%, 71.5%, 85.8%, and 100% for fluconazole, voriconazole, caspofungin, and micafungin, respectively. The minor errors (MiE) of 14.2% for fluconazole and caspofungin, 28.5% for voriconazole, were detected in C. albicans. In C. glabrata, the categorical agreement (CA) was 100% for micafungin, voriconazole, but 63.7% for caspofungin. An MiE of 36.3% was detected for caspofungin. C. parapsilosis showed a 100% CA for fluconazole, caspofungin, and micafungin, and 85.8% for voriconazole. There were 14.2% of MiEs for voriconazole. In C. tropicalis, 100 % CA was observed for fluconazole, micafungin, and caspofungin, and 88.9% for voriconazole. Moreover, 11.1% (1/9) of MiEs was observed for voriconazole. In C. auris, there was a 100% CA for caspofungin and micafungin, 77.8% for fluconazole, and 66.7% for amphotericin B. There was a major error of 22.2% for fluconazole and 33.3% for amphotericin B.
Conclusion: The majority of Vitek 2C showed comparable results with the broth microdilution (BMD) method. Only minor errors (MiEs) were observed in the tested Candida species.
Research Article: Research Article |
Subject:
Mycology
Received: 2023/04/20 | Accepted: 2024/09/23 | Published: 2025/04/16 | ePublished: 2025/04/16
Received: 2023/04/20 | Accepted: 2024/09/23 | Published: 2025/04/16 | ePublished: 2025/04/16
References
1. Lee H, Choi SH, Oh J, Koo J, Lee HJ, Cho SI, et al. Comparison of Six Antifungal Susceptibilities of 11 Candida Species Using the VITEK2 AST-YS08 Card and Broth Microdilution Method. Microbiol Spectr. 2022; 10: e0125321. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Peterson JF, Pfaller MA, Diekema DJ, Rinaldi MG, Riebe KM, Ledeboer NA. Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. J Clin Microbiol. 2011; 49: 1765-71. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Melhem MS, Bertoletti A, Lucca HR, Silva RB, Meneghin FA, Szeszs MW. Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species. Braz J Microbiol. 2014; 44: 1257-66. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. CDC Candida auris: information for laboratorians and health professionals. Atlanta, Georgia: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/fungal/candida-auris/health-professionals.html [View at Publisher]
5. CLSI. Performance Standards for Antifungal Susceptibility Testing of Yeasts. 3rd ed. CLSI supplement M27M44S. Clinical and Laboratory Standards Institute; 2022. [View at Publisher]
6. CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, 4th Edition. CLSI standard M27.Wayne,PA:Clinical and Laboratory Standards Institute; 2017. [View at Publisher]
7. Cuenca-Estrella M, Gomez-Lopez A, Alastruey-Izquierdo A, Bernal-Martinez L, Cuesta I, Buitrago MJ, et al. Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. J Clin Microbiol. 2010; 48: 1782-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Cejudo MA, Gallego AG, Lacasa EC, Aller AI, Romero A, García JP, et al. Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method. Med Mycol. 2010; 48: 710-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Borghi E, Iatta R, Sciota R, Biassoni C, Cuna T, Montagna MT, Morace G. Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study. J Clin Microbiol. 2010; 48: 3153-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J Clin Microbiol. 2007; 45: 796-802. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Bourgeois N, Dehandschoewercker L, Bertout S, Bousquet PJ, Rispail P, Lachaud L. Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods. J Clin Microbiol. 2010; 48: 154-61. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Lim HJ, Shin JH, Kim MN, Yong D, Byun SA, Choi MJ, et al. Evaluation of two commercial broth microdilution methods using different interpretive criteria for the detection of molecularmechanisms of acquired azole and echinocandin resistance in four commonCandida species. Antimicrob Agents Chemother 2020;64:e00740-20. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Welsh RM, Sexton DJ, Forsberg K, Vallabhaneni S, Litvintseva A. Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris. J Clin Microbiol. 2019; 57:e00007-19. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Rajmane SV, Mohite TS. Comparison of the VITEK 2 Yeast Antifungal Susceptibility Testing with CLSI Broth Microdilution Reference Method for Testing Four Antifungal Drugs against Candida species Isolated from Blood Samples. JKIMSU. 2018; 7: 40-46. [View at Publisher] [Google Scholar]
15. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Diagn Microbiol Infect Dis. 2013;77:37-40. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Wong KY, Gardam D, Boan P. Comparison of Vitek 2 YS08 with Sensititre YeastOne for Candida susceptibility testing. Pathology. 2019; 51: 668-669. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.